Sodium hydroxide:pH calculation,Uses,Health hazards

Liquid sodium hydroxide is colorless and has no odor. It can react violently with strong acids and with water.

Mar 6,2024  Inorganic chemistry

Q:How long can a dog with congestive heart failure survive on Pimobendan?

A:In general, dogs diagnosed with congestive heart failure can live from 6 months to 1.5 or 2 years.

Mar 6,2024  Drugs

Ceftiofur sodium: Uses, Mechanism of action and Side effects

Ceftiofur sodium is a third-generation cephalosporin antibiotic active against Gram-positive and Gram-negative bacteria, including beta-lactamase-producing strains.

Mar 6,2024  Drugs

Veterinary drug Marbofloxacin: Uses, Mechanism of action, Adverse reactions and Toxicity

Marbofloxacin is a synthetic fluoroquinolone veterinary-specific antimicrobial drug with broad-spectrum antibacterial activity against both Gram-negative and Gram-positive bacteria.

Mar 6,2024  Drugs

The warnings and precautions of Brigatinib

ALUNBRIG (Brigatinib) is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an

Mar 6,2024  API

The synthesis and applications of Fmoc-Phe-OH

Fmoc-Phe-OH is a key compound in the field of peptide synthesis, playing an important role as a building block in the process of peptide assembly.

Mar 6,2024  API

The Role and Synthesis of Platinum(0)-1,3-Divinyl-1,1,3,3-Tetramethyldisiloxane Complexes in Catalysis

Platinum (0) -1,3-diethylene-1,1,3,3-tetramethyldisiloxane, with its excellent stability, reactivity, and selectivity, heralds a new era of catalysis.

Mar 6,2024  API

The Applications and Mechanism of Action of AZD 3759

AZD 3759 is a novel inhibitor targeting EGFR tyrosine kinase, which has been used in clinical treatment and other aspects.

Mar 6,2024  API

Liposomal bupivacaine: Overview, Efficacy in Postoperative Pain and Safety

Liposomal bupivacaine provides extended postoperative pain relief with good safety. Adverse effects include nausea, vomiting, and headache. Caution is advised for wider application.

Mar 6,2024  API

Olmesartan Medoxomil: Pharmacokinetics and Clinical Applications

Olmesartan medoxomil, rapidly converted to olmesartan, is a common angiotensin II receptor blocker effective in treating hypertension, heart failure, and diabetic nephropathy.

Mar 6,2024  API
Prev12345678910...Next>  Go to Page